Coughs and wheezes spread diseases: But what about the environment?

Thorax

Volumn 61, Issue 5, 2006, Pages 367-368

  Bush, A ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN;

ASTHMA; ATOPY; CLINICAL PRACTICE; COUGHING; EDITORIAL; PHENOTYPE; PRIORITY JOURNAL; RHINOVIRUS; VIRAL RESPIRATORY TRACT INFECTION; WHEEZING;

ALLERGENS; ASTHMA; CHILD, PRESCHOOL; COUGH; HUMANS; RESPIRATORY HYPERSENSITIVITY; RESPIRATORY SOUNDS; RESPIRATORY TRACT INFECTIONS; VIRUS DISEASES;

EID: 33646587063     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2005.048389     Document Type: Editorial

References (28)

1. McKean M, Ducharme F. Inhaled steroid for episodic viral wheeze of childhood. Cochrane Database Syst Rev 2000;(2):CD001107.
2. Knorr B, Franchi LM, Bisgaard H, et al. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years. Pediatrics 2001;108:E48.
3. Bisgaard H. A randomised trial of montelukast in respiratory syncytial virus postbronchiolitis. Am J Respir Crit Care Med 2003;167:379-83.
4. Robertson CF, Henry RL, Mellis C, et al. Short course montelukast for intermittent asthma in children: the Pre-empt study. Am J Respir Crit Care Med 2004;169:A149.
5. Murray CS, Poletti G, Kebadze T, et al. Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children. Thorax 2006;61:376-82.
6. Green RM, Custovic A, Sanderson G, et al. Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study. BMJ 2002;324:763-6.
7. Wilson N, Sloper K, Silverman M. Effect of continuous treatment with topical corticosteroid on episodic viral wheeze in preschool children. Arch Dis Child 1995;72:317-20.
8. Martinez FD, Wright AL, Taussig LM, et al. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 1995;332:133-8.
9. Turner SW, Palmer U, Rye PJ, et al. Infants with flow limitation at 4 weeks: outcome at 6 and 11 years. Am J Respir Crit Care Med 2002;165:1294-8.
10. Turner SW, Palmer LJ, Rye PJ, et al. The relationship between infant airway function, childhood airway responsiveness, and asthma. Am J Respir Crit Care Med 2004;169:921-7.
11. Lowe LA, Simpson A, Woodcock A, and the NAC Manchester Asthma and Allergy Study Group, et al. Wheeze phenotypes and lung function in preschool children. Am J Respir Crit Care Med 2005;171:231-7.
12. Silverman M, Wilson NM. Wheezing phenotypes in childhood. Thorax 1997;52:936-7.
13. Brooke AM, Lambert PC, Burton PR, et al. The natural history of respiratory symptoms in preschool children. Am J Respir Crit Care Med 1995;152:1872-8.
14. Morgan WJ, Stern DA, Sherrill DL, et al. Outcome of asthma and wheezing in the first 6 years of life: follow-up through adolescence. Am J Respir Crit Care Med 2005;172:1253-8.
15. Saglani S, Malmstrom K, Pelkonen AS, et al. Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction. Am J Respir Crit Care Med 2005;171:722-7.
16. Hogg JC. Role of latent viral infections in chronic obstructive pulmonary disease and asthma. Am J Respir Crit Care Med 2001;164:S71-5.
17. Ball TM, Castro-Rodriguez JA, Griffith KA, et al. Siblings, day-care attendance, and the risk of asthma and wheezing during childhood. N Engl J Med 2000;343:538-43.
18. Sigurs N, Gustafsson PM, Bjarnason R, et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med 2005;171:137-41.
19. Stein R, Sherrill D, Morgan WJ, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999;354:541-5.
20. O'Donnell DR, Openshaw PJ. Anaphylactic sensitization to aeroantigen during respiratory virus infection. Clin Exp Allergy 1998;28:1501-8.
21. Langley SJ, Goldthorpe S, Craven M, et al. Relationship between exposure to domestic allergens and bronchial hyperresponsiveness in non-sensitised, atopic asthmatic subjects. Thorax 2005;60:17-21.
22. Tortorolo L, Langer A, Polidori G, et al. Neurotrophin overexpression in lower airways of infants with respiratory syncytial virus infection. Am J Respir Crit Care Med, 2005;172, 233-7.
23. Chalmers GW, Macleod KJ, Little SA, et al. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax 2002;57:226-30.
24. Chaudhuri R, Livingston E, McMahon AD, et al. Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. Am J Respir Crit Care Med 2003;168:1308-11.
25. Tomlinson JE, McMahon AD, Chaudhuri R, et al. Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma. Thorax 2005;60:282-7.
26. Oommen A, Lambert PC, Grigg J. Efficacy of a short course of parent-initiated oral prednisolone for viral wheeze in children aged 1-5 years: randomised controlled trial. Lancet 2003;362:1433-8.
27. Aurora P, Stocks J, Oliver C, on behalf of LCCF, et al. Quality control for spirometry in preschool children with and without lung disease. Am J Respir Crit Care Med 2004;169:1152-9.
28. Aurora P, Bush A, Gustafsson P, et al. Multiple breath washout as a marker of lung disease in preschool children with cystic fibrosis. Am J Respir Crit Care Med 2005;171:249-56.